Table 3.
Intervention | ||||
---|---|---|---|---|
Drug class/intervention strategy | Drug/intervention | Efficacy | Safety | Practice implications |
Dopamine agonists | Piribedil a | Likely efficacious | Acceptable risk without specialized monitoring | Possibly useful |
Rotigotine | Unlikely efficacious | Acceptable risk without specialized monitoring | Investigational | |
Acetylcholinesterase inhibitors | Rivastigmine | Efficacious | Acceptable risk without specialized monitoring b | Possibly useful |
Recommendations apply only for PD patients following STN stimulation.
Worsening of tremor may occur in some patients treated with cholinesterase inhibitors. Medical monitoring for cholinergic effects could include blood pressure or electrocardiograph monitoring but acetylcholinesterase inhibitors are considered to pose an acceptable risk even without specialized monitoring.2